This Hockey Great Could Make You a Better Investor 🏒

Investors miss 100% of the stocks they don't buy. And there's one opportunity in a promising - and undervalued - sector of the market that you don't want to miss. SPECIAL OPPORTUNITIES [The Oxford Club Special Opportunities]( Note From Senior Managing Editor Nicole Labra: You don't have to be a hockey fan to understand the meaning behind one of Wayne Gretzky's most memorable quotes: "You miss 100% of the shots you don't take." As Chief Investment Strategist Alexander Green explains in today's article, investors miss 100% of the winning stocks they don't buy. And here's one shot you're going to want to take... Cancer has often been a death sentence - but that's changing thanks to the ingenuity of the scientists at [this one tiny company with a low share price](. Now tens of thousands of people have a new lease on life. Science magazine calls [this medical breakthrough]( a "homing device" that leaves healthy cells alone... And BioWorld simply calls it [a "landmark" new FDA-approved drug](... [Go here]( to learn more about the stock you don't want to miss. --------------------------------------------------------------- The Best Small Cap Play Out There Alexander Green, Chief Investment Strategist, The Oxford Club [Alexander Green] Twenty years ago, I heard a stand-up comic ask the audience, "What's the definition of a sports nut?" The punch line: "Anyone who can name a hockey player other than Wayne Gretzky." Longtime fans of the sport will scoff. But let's be honest... "The Great One" was to hockey what Bob Marley was to reggae: the category killer. In his 21 years, Gretzky scored 894 goals and had 1,963 assists. (No player in history has as many goals and assists combined as he has assists alone.) Asked over the years how he managed this feat, Gretzky gave two answers that have become legendary. - "You miss 100% of the shots you don't take." - "I skate to where the puck is going to be, not where it has been." For investors, there is a lot of wisdom in those words. Just as you miss 100% of the shots you don't take, [you miss 100% of the winning stocks you don't buy](. How many millions of investors watched the parabolic rise in value of stocks like Apple (Nasdaq: AAPL), Amazon (Nasdaq: AMZN), Netflix (Nasdaq: NFLX) and Tesla (Nasdaq: TSLA) - all up more than 100-fold - and never thought the time was right to invest in them ever? They missed 100% of their potential shots. Skating to where the puck was - rather than where it is going to be - is called "performance chasing" in the investment world. Twenty-three years ago, investors chased dot-com stocks. They crashed and burned. A decade later they rushed to make furious above-market bids on residential real estate. The property market imploded. (And there is good evidence that another property bubble is developing today.) Crypto speculators - I refuse to call them "investors" - chased Bitcoin and other digital currencies into the stratosphere. Now most are sitting on big losses. Over a year ago, investors fell in love with "disruptive" tech companies that were not only pre-earnings but pre-revenue. Result? Cathie Wood's Ark Innovation ETF (NYSE: ARKK) - a good proxy for the "no price is too high to pay" approach to investing - fell from grace. These investors all ignored Gretzky's sage advice. They skated to where the puck had been rather than where it was going to be. This is a perennial problem. Today, for example, most investors are chasing the same small group of "value stocks," the new investment du jour that has outperformed the market in recent months. True, there is still some upside here. But Oxford Club Members picked up value stocks like CVS Health (NYSE: CVS), Energy Select Sector SPDR Fund (NYSE: XLE), Arch Capital (Nasdaq: ACGL) and Berkshire Hathaway (NYSE: BRK-B) more than a year ago. Now we're sitting on big profits and cashed out on others. We didn't buy them because they were in favor but precisely because they were out of favor. Want to skate now to where the puck will soon be? Then invest a few dollars in one of the most promising and undervalued sectors in the market right now: [small cap medical technology](. There are three good reasons to [expect big returns here in the weeks and months ahead](. - Healthcare is recession-resistant. It doesn't matter whether the economy is expanding or contracting, whether inflation is hotter or colder, or whether interest rates are rising or falling. People who need medical attention will seek it and find it. You can take economic forecasting off the table. The demand for medical services is largely inelastic. - Innovation is constant. New medical devices are protecting, extending and saving our lives. Virtually all are patent protected. That stops competition, puts a moat around profit margins, and drives strong top- and bottom-line growth. - It's the perfect contrarian investment. Technology stocks have been hit hard this year. But small cap tech stocks - including those in the medical field - are lying in the bargain bin, unloved and undervalued. And therein lies [a huge opportunity](. I recently pinpointed [a medical technology stock with an affordable share price]( that has all of the makings of a superb investment. In my latest presentation, I explain why medical technology is where the puck is going to be - and reveal [the name (and ticker symbol) of one of the most exciting innovators in the sector](. The only question Wayne Gretzky would ask at this point is "Will you take the shot?" Good investing, Alex OPPORTUNITIES FROM FRIENDS OF THE CLUB - [How "Woke Capitalism" Is CRUSHING the Stock Market]( - [Could "XRI" Spark the Biggest Investment Boom Since the Internet?]( - [Is It Time to Quit the Market?]( SPONSORED [Cure for RED in Your Portfolio?]( [Downward Trend]( If you are looking at nothing but red right now... A former CBOE trading legend wants to help you. During the COVID Crash... he showed members 246% total gains while the S&P was DOWN 20%. Now he's teaching a FREE LESSON revealing how BIG market volatility can make you even BIGGER gains. [He's Going LIVE Today - Click Here to Join Him FREE!]( [The Oxford Club] You are receiving this email because you subscribed to Oxford Club Special Opportunities. Oxford Club Special Opportunities is published by The Oxford Club. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. [Privacy Policy]( | [Whitelist Oxford Club Special Opportunities]( | [Unsubscribe]( © 2023 The Oxford Club, LLC All Rights Reserved The Oxford Club | [105 West Monument Street](#) | [Baltimore, MD 21201](#) North America: [1.800.589.3430](#) | International: [+1.443.353.4334](#) | Fax: [1.410.329.1923](#) [Oxfordclub.com]( Your Legal Questions... Answered What is The Oxford Club? The Oxford Club is a financial publisher with a highly rated track record. We deliver unique and well-researched financial and investment ideas to our Members. What do you do? We share our team of experts' industry knowledge and timely insights with our Members so they have the financial literacy and tools needed to build a rich, fulfilling life. We do not provide any personalized financial advice or advocate the purchase or sale of any security or investment for any specific individual. Instead, the information we share is directed toward a larger audience of all subscribed Members. So you'll make me rich? Maybe! But not exactly. Our goal is to provide the research and information required to help you make you rich. Investment markets have inherent risks, and we can't guarantee future profits. Why should I trust you? We offer information based on what we think will provide the most value to our Members. Our business depends on Members' interest in our ideas and satisfaction with their results. We've been around for 30-plus years because our Members have continually chosen to stay with us (many of them for life). Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Should I still consult my investment advisor? Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.